US Broker Ratings

Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring Growth Potential and Market Position

Aurora Cannabis Inc. (ACB), a prominent player in the healthcare sector under the Drug Manufacturers – Specialty & Generic industry, is headquartered in Edmonton, Canada. With a market capitalization of..

Absci Corporation (ABSI) Stock Analysis: A Deep Dive into Its 239% Potential Upside

Absci Corporation (NASDAQ: ABSI), a pioneering force in the biotechnology sector, is attracting investor attention with its innovative approach to drug creation using generative artificial intelligence. This Washington-based company leverages..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating a Challenging Landscape with a 7.15% ROE

Zhengye Biotechnology Holding Limited (ZYBT) is a notable player within the healthcare sector, specifically in the niche of drug manufacturing specializing in veterinary vaccines. Despite the company’s robust market presence..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: A 29% Potential Upside Amid Bold Biotech Innovations

Cidara Therapeutics, Inc. (CDTX), a prominent player in the biotechnology industry, is captivating investor attention with its innovative approach to tackling serious diseases through targeted therapies. Based in San Diego,..

Alpha Teknova, Inc. (TKNO): Investor Outlook with a Promising 116% Upside Potential

Alpha Teknova, Inc. (NASDAQ: TKNO), a burgeoning entity within the healthcare sector, stands at a pivotal junction that could potentially deliver a substantial upside for investors. Operating in the specialized..

NeoGenomics, Inc. (NEO) Stock Analysis: Unveiling Growth Potential with a 53.90% Upside

NeoGenomics, Inc. (NASDAQ: NEO) is a key player in the diagnostics and research industry, focusing on cancer-related testing through its comprehensive network of laboratories in the United States and the..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 96% Potential Upside in the Biotech Space

MiMedx Group, Inc (NASDAQ: MDXG) stands out as a compelling investment opportunity within the biotechnology sector, backed by a robust market presence and innovative healthcare solutions. With a market capitalization..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 12.56% Upside Potential with Robust Revenue Growth

The Pennant Group, Inc. (NASDAQ: PNTG), a healthcare services provider based in Eagle, Idaho, presents a compelling opportunity for investors with its promising growth trajectory. Specializing in Home Health and..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Exploring the 27.6% Upside Potential

For investors seeking exposure in the healthcare sector, particularly in the medical devices industry, Establishment Labs Holdings Inc (NASDAQ: ESTA) presents an intriguing opportunity. Headquartered in Alajuela, Costa Rica, this..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 167.92% Potential Upside in the Biotech Sector

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a burgeoning name in the biotechnology industry, is drawing significant attention from investors with a notable potential upside of 167.92%. This clinical-stage biopharmaceutical company, headquartered..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unpacking a 213% Potential Upside in the Biotech Space

Wave Life Sciences Ltd. (NASDAQ: WVE), a prominent player in the biotechnology sector, is making waves with its innovative approach to RNA medicine. Based in Singapore, this clinical-stage biotech company..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring the 93% Upside Potential in Biotech’s Visionary Play

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on innovative therapies for eye diseases, is currently capturing investor attention with a promising 93% potential upside. With its headquarters in..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Navigating a Pivotal Year with 5.70% Revenue Growth

Healthcare Services Group, Inc. (NASDAQ: HCSG), a key player in the healthcare sector, operates within the medical care facilities industry. Known for its comprehensive management and operational services for housekeeping..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a 24% Upside Potential with Robust Revenue Growth

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a specialty and generic drug manufacturer headquartered in Baudette, Minnesota, is capturing investor attention with its significant revenue growth and a robust potential upside. As..

Dynavax Technologies Corporation (DVAX): Investor Outlook Reveals 134.63% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is a company that’s garnering attention in the healthcare sector, particularly among those invested in specialty drug manufacturing. With its primary focus on vaccine development..

Kestra Medical Technologies (KMTS) Stock Analysis: A 65.86% Upside Potential in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might want to keep a close eye on Kestra Medical Technologies, Ltd (KMTS). With a strong potential upside of 65.86% based on..

Evotec SE (EVO) Stock Analysis: A 46% Potential Upside Amidst Strategic Collaborations

Evotec SE (EVO), headquartered in Hamburg, Germany, is carving out a significant niche in the healthcare sector as a pivotal player in drug discovery and development. With a current market..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 202% Upside Potential Despite Current Challenges

Opko Health, Inc. (NASDAQ: OPK), a key player in the healthcare sector, operates within the diagnostics and pharmaceuticals industries. With a market capitalization of $1.05 billion, the Miami-based company is..

Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Contender with a 92% Potential Upside

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, has been attracting significant attention from investors due to its substantial growth potential and strategic positioning within the medical..

Travere Therapeutics, Inc. (TVTX): Investor Outlook Reveals 131.53% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biotechnology company specializing in rare kidney and metabolic diseases, has been garnering significant attention from investors, and for good reason. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds